CLINICAL_TRIALS
trial_result
· 2020-09-17
Clinical Trial Update: RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR [Phase 2]
Summary
Phase 2 trial of RTA 408 (omaveloxolone) in patients with mitochondrial myopathy has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: MItochondrial Myopathies | Phase 2 | Status: COMPLETED | Results posted: 2020-09-17